Bicycle Therapeutics (BCYC) Interest Coverage Ratio Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,150.63% |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | 0.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.90% |
| Dec 31, 2025 | 66.69% |
| Sep 30, 2025 | 23.00% |
| Jun 30, 2025 | -2,732.94% |
| Mar 31, 2025 | -3,463.33% |
| Dec 31, 2024 | -1,867.35% |
| Sep 30, 2024 | -3,000.32% |
| Jun 30, 2024 | -7.81% |
| Mar 31, 2024 | 25.33% |
| Dec 31, 2023 | -69.61% |
| Sep 30, 2023 | -71.32% |
| Jun 30, 2023 | -69.84% |
| Mar 31, 2023 | -54.55% |
| Dec 31, 2022 | -77.41% |
| Sep 30, 2022 | -109.72% |
| Jun 30, 2022 | -46.56% |
| Mar 31, 2022 | -9.05% |